KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 201 filers reported holding KARUNA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 1.18 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,780,685 | -43.6% | 16,445 | -27.6% | 0.17% | -37.1% |
| Q2 2023 | $4,927,483 | -56.9% | 22,723 | -63.9% | 0.27% | -60.5% |
| Q1 2023 | $11,443,320 | -26.7% | 63,000 | -20.7% | 0.68% | -30.1% |
| Q4 2022 | $15,615,069 | -28.2% | 79,466 | -17.8% | 0.97% | -29.7% |
| Q3 2022 | $21,752,000 | +68.6% | 96,706 | -5.2% | 1.38% | +83.8% |
| Q2 2022 | $12,900,000 | -51.6% | 101,971 | -51.5% | 0.75% | -36.4% |
| Q1 2022 | $26,637,000 | -11.4% | 210,084 | -8.4% | 1.18% | +11.0% |
| Q4 2021 | $30,059,000 | +120.2% | 229,455 | +105.6% | 1.06% | +124.1% |
| Q3 2021 | $13,653,000 | -39.8% | 111,604 | -43.9% | 0.47% | -36.3% |
| Q2 2021 | $22,695,000 | +3.7% | 199,096 | +9.4% | 0.74% | +2.3% |
| Q1 2021 | $21,879,000 | – | 181,976 | – | 0.73% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 782,008 | $142,043,933 | 58.49% |
| Nan Fung Group Holdings Ltd | 225,688 | $40,993,968 | 27.90% |
| Sofinnova Investments, Inc. | 1,773,124 | $322,070,243 | 20.60% |
| Artia Global Partners LP | 88,831 | $16,135,263 | 5.96% |
| DAFNA Capital Management LLC | 78,573 | $14,272,000 | 4.28% |
| First Light Asset Management, LLC | 243,675 | $44,261,127 | 3.98% |
| CATALYST PRIVATE WEALTH, LLC | 21,837 | $3,966,473 | 2.74% |
| Sands Capital Ventures, LLC | 58,895 | $10,697,688 | 2.64% |
| ARCH Venture Management, LLC | 30,000 | $5,449,200 | 2.63% |
| Logos Global Management LP | 100,000 | $18,164,000 | 2.60% |